Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Katayama (Sakai, Japan), K. Tsuyuguchi (Sakai, Japan), Y. Kurahara (Sakai, Japan), T. Kobayashi (Sakai, Japan), N. Takeuchi (Sakai, Japan), T. Arai (Sakai, Japan), Y. Inoue (Sakai, Japan), K. Suzuki (Sakai, Japan). Neutrophil-predominant effusion as a predictive factor for outcome in tuberculous pleurisy. 2757

Member's Comments

No comment yet.

Related content which might interest you: The diagnostic value of interleukin-6 in distinguishing tuberculous pleurisy from malign effusion Source: Eur Respir J 2001; 18: Suppl. 33, 499s Year: 2001 Use of cytokines in the diagnosis and outcome correlation of tuberculous pleural effusion Source: Eur Respir J 2002; 20: Suppl. 38, 210s Year: 2002 Predictors of residual pleural opacity in tuberculous pleurisy Source: Annual Congress 2007 - Clinical tuberculosis Year: 2007 Videothoracoscopy as a diagnostic tool of the syndrome of tuberculous pleural effusion Source: Eur Respir J 2005; 26: Suppl. 49, 413s Year: 2005 The value of interferon (IFN)-γ pleural effusion tests in diagnosis of tuberculosis Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007 Role of C-reactive protein in discriminating complicated and uncomplicated parapneumonic effusion from malignant and tuberculous pleural effusion Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status Year: 2021 Predictive factors, microbiology and outcome of patients with parapneumonic effusion Source: Eur Respir J 2011; 38: 1173-1179 Year: 2011 Profibrotic implication of platelet-activating factor in tuberculous pleural effusion Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Value of chitotriosidase enzyme activity in discrimination of tuberculous pleurisy from malignant pleural effusion Source: Annual Congress 2010 - Extrapulmonary tuberculosis Year: 2010 Clinical and epidemiological features of tuberculous pleural effusion Source: Eur Respir J 2005; 26: Suppl. 49, 657s Year: 2005 Is ²blind² pleural biopsy still of value in tuberculous effusions? Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives Year: 2008 Bactec versus histopathology in the clinical diagnosis of tuberculous pleural effusion Source: Eur Respir J 2001; 18: Suppl. 33, 472s Year: 2001 Features of patients with tuberculous pleurisy Source: Eur Respir J 2001; 18: Suppl. 33, 310s Year: 2001 The value of adenosin-deaminase in etiologic diagnosis of pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 167s Year: 2002 Diagnostic assessment in tuberculous pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 413s Year: 2005 The diagnostic value of interferon gamma in differantial diagnosis of tuberculous pleurisy Source: Eur Respir J 2001; 18: Suppl. 33, 310s Year: 2001 Pleural effusion in patients with IgG4-related disease: Investigated features and compared to tuberculous pleurisy Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020 Diagnostic value of leptin in tuberculous pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 426s Year: 2004 A consideration for the necessity of pleural biopsy in diagnosing tuberculous pleurisy Source: Annual Congress 2007 - Immunology and genetics of tuberculosis Year: 2007 Clinical and bacteriological aspects in tuberculous pleural effusions Source: Annual Congress 2007 - Tuberculosis Year: 2007